BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10068106)

  • 1. Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication.
    Vásconez C; Elizalde JI; Llach J; Ginès A; de la Rosa C; Fernández RM; Mas A; Santamaría J; Bordas JM; Piqué JM; Terés J
    J Hepatol; 1999 Feb; 30(2):260-4. PubMed ID: 10068106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients.
    Chen SJ; Wang LJ; Zhu Q; Cai JT; Chen T; Si JM
    World J Gastroenterol; 2008 Mar; 14(12):1914-8. PubMed ID: 18350632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients].
    Wang LJ; Cai JT; Chen T; Lü B; Si JM
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):654-7. PubMed ID: 17074151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
    Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication.
    Agrawal A; Gupta A; Chandra M; Koowar S
    Indian J Gastroenterol; 2011 Feb; 30(1):29-32. PubMed ID: 21416318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions.
    Zullo A; Hassan C; Morini S
    Dig Liver Dis; 2003 Mar; 35(3):197-205. PubMed ID: 12779075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection.
    Dasani BM; Sigal SH; Lieber CS
    Am J Gastroenterol; 1998 May; 93(5):726-31. PubMed ID: 9625117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.
    Scotiniotis IA; Lucey MR; Metz DC
    Dig Dis Sci; 2001 Dec; 46(12):2744-51. PubMed ID: 11768268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence and role of Helicobacter pylori infection in some gastroduodenal and hepatic complications in cirrhotic patients].
    Săndulache L; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):890-5. PubMed ID: 20209758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review.
    Schulz C; Schütte K; Malfertheiner P
    J Clin Gastroenterol; 2014 Jul; 48(6):491-9. PubMed ID: 24583758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy.
    Miquel J; Barcena R; Boixeda D; Fernández J; SanRoman AL; Martín-de-Argila C; Ramosa F
    Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1067-72. PubMed ID: 11564957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].
    García-Romero E; del Val A; Garrigues V; Cuquerella J; Higón MD; Barrachina M; Pons V; Bixquert M; Ponce J
    Gastroenterol Hepatol; 1999 Jan; 22(1):1-6. PubMed ID: 10089703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Helicobacter pylori Infection in Patients with Minimal Hepatic Encephalopathy.
    Schulz C; Schütte K; Reisener N; Voss J; Malfertheiner P
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):191-5. PubMed ID: 27308650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori, gastric juice, and arterial ammonia levels in patients with cirrhosis.
    Chakrabarti P; Zullo A; Hassan C; Pandit A; Chowdhury A; Santra A; Hazra B; Morini S; Roy T
    J Clin Gastroenterol; 2002; 34(5):578-81. PubMed ID: 11960074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
    Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.
    Zullo A; Rinaldi V; Meddi P; Hassan C; Winn S; Attili AF
    Am J Gastroenterol; 1999 Aug; 94(8):2214-8. PubMed ID: 10445552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.
    Miyaji H; Ito S; Azuma T; Ito Y; Yamazaki Y; Ohtaki Y; Sato F; Hirai M; Kuriyama M; Kohli Y
    Gut; 1997 Jun; 40(6):726-30. PubMed ID: 9245925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.